HSIC vs QURE · P/E 24, rev $6.83B vs rev $16.1M
Henry Schein Inc (HSIC) versus Uniqure NV (QURE) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. QURE currently screens at market cap $3.04B.
Not investment advice. Open the HSIC and QURE stock pages for the full models.
Not investment advice.